EntityQ5434391· pop 6· linked from 322 articles

fantofarone

Fantofarone is a calcium channel blocker.

Research

51 papers

Fantofarone (SR 33557): effect on post-ischaemic functional recovery in perfused rat hearts.European journal of pharmacology · 1992
Fantofarone (SR 33557): cardiovascular actions in anesthetized dogs.Archives internationales de pharmacodynamie et de therapie · 1994
Effects of two chemically related new Ca2+ channel antagonists, SR33557 (fantofarone) and SR33805, on the L-type cardiac channel.European journal of pharmacology · 1994
Interaction of the calcium antagonist fantofarone with phospholipids: electrostatic effects.Biochemical pharmacology · 1994
Fantofarone (SR33557): effects on myocardial oxygen consumption and coronary blood flow.Pharmacology · 1994

via PubMed

Article

2 sections

Contents

Comparison with verapamil
References

{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 346459924 | ImageFile=Fantofarone.svg | ImageSize= | PIN=N-[2-(3,4-Dimethoxyphenyl)ethyl]-N-methyl-3-{4-[2-(propan-2-yl)indolizine-1-sulfonyl]phenoxy}propan-1-amine | OtherNames= |Section1= |Section2= |Section3= }}

Fantofarone is a calcium channel blocker.